Cannara Biotech (CNBTF) Stock Price, News & Analysis

Company Overview

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques. In addition to finished product lines, Cannara Biotech provides contract research and toll-manufacturing services, supporting partners in the development and scale-up of plant-based formulations under quality-controlled conditions.

Through GMP-aligned processing facilities, Cannara Biotech maintains rigorous quality assurance across its production network. While detailed corporate history and executive leadership information are limited in public disclosures, the company remains focused on expanding its biotechnological capabilities and strategic collaborations to address emerging market demands in natural health and wellness.

Key Stats

• Today's Range: $1.37 to $1.39
• 50-Day Range: $1.12 to $1.42
• 52-Week Range: $0.08 to $0.20
• Volume: 10,829 shs
• Average Volume: 33,127 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CNBTF
• CIK: N/A
• Web: cannara.ca
• Phone: N/A
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A